This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Stephen T. Warren, PhD; David L. Nelson, PhD

JAMA. 1994;271(7):536-542.

Abstract
Fragile X syndrome is a common cause of mental retardation that is inherited as an X-linked dominant disorder with reduced penetrance. Fragile X syndrome has been shown to be caused by an unstable CGG repeat within the fragile X mental retardation—1 (FMR1) gene. The repeat is normally polymorphic with six to 52 repeats, while affected males and females exhibit a massive expansion resulting in 230 to more than 1000 repeats. Such expansions, called "full mutations," are associated with abnormal methylation of the FMR1 gene leading to transcriptional suppression. The resulting absence of the encoded protein, FMRP, a cytosolic RNA-binding protein, is believed to result in the phenotype. Nonpenetrant male carriers and many female carriers exhibit premutation alleles of intermediate length (50 to 230 repeats), which are normally expressed. Male carriers transmit only unstable premutations while female premutation carriers can have carrier offspring with premutations or affected children with full mutations. The risk of having an affected child is directly related to the number of maternal repeats, with sequentially increasing probabilities of these alleles converting to full mutations as they are transmitted to subsequent generations. Advances have led to highly accurate laboratory diagnoses of both carrier and affected individuals as well as markedly improved prenatal diagnosis. In addition, a previously unrecognized class of mutation, later found responsible for several other important genetic diseases, has emerged.

(JAMA. 1994;271:536-542)

Author Affiliations
From the Howard Hughes Medical Institute, Departments of Biochemistry and of Pediatrics, Emory University School of Medicine, Atlanta, Ga (Dr Warren), and Institute for Molecular Genetics and Human Genome Center, Baylor College of Medicine, Houston, Tex (Dr Nelson).

Footnotes
Reprint requests to Howard Hughes Medical Institute, Emory University School of Medicine, Room 4035, Rollins Research Center, 1510 Clifton Rd NE, Atlanta, GA 30322 (Dr Warren).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Limbic Epileptogenesis in a Mouse Model of Fragile X Syndrome
Qiu et al.
Cereb Cortex 2009;19:1504-1514.
ABSTRACT | FULL TEXT  

Altered Hippocampal Synaptic Plasticity in the Fmr1 Gene Family Knockout Mouse Models
Zhang et al.
J. Neurophysiol. 2009;101:2572-2580.
ABSTRACT | FULL TEXT  

Fragile X Mental Retardation Protein Shifts between Polyribosomes and Stress Granules after Neuronal Injury by Arsenite Stress or In Vivo Hippocampal Electrode Insertion
Kim et al.
J. Neurosci. 2006;26:2413-2418.
ABSTRACT | FULL TEXT  

From the Cover: Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses
Weiler et al.
Proc. Natl. Acad. Sci. USA 2004;101:17504-17509.
ABSTRACT | FULL TEXT  

A single base alteration in the CGG repeat region of FMR1: possible effects on gene expression and phenotype
Tarleton et al.
J. Med. Genet. 2002;39:196-200.
FULL TEXT  

Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles
Dombrowski et al.
Hum Mol Genet 2002;11:371-378.
ABSTRACT | FULL TEXT  

Microdeletion in the FMR-1 gene: an apparent null allele using routine clinical PCR amplification
Hegde et al.
J. Med. Genet. 2001;38:624-629.
FULL TEXT  

Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers
Kenneson et al.
Hum Mol Genet 2001;10:1449-1454.
ABSTRACT | FULL TEXT  

The fragile X mental retardation protein inhibits translation via interacting with mRNA
Li et al.
Nucleic Acids Res 2001;29:2276-2283.
ABSTRACT | FULL TEXT  

MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M
Zhu and Chen
Mol. Cell. Biol. 2000;20:5602-5618.
ABSTRACT | FULL TEXT  

Understanding the molecular basis of fragile X syndrome
Jin and Warren
Hum Mol Genet 2000;9:901-908.
ABSTRACT | FULL TEXT  

The Human 20-kDa 5'-(CGG)n-3'-binding Protein Is Targeted to the Nucleus and Affects the Activity of the FMR1 Promoter
Muller-Hartmann et al.
J. Biol. Chem. 2000;275:6447-6452.
ABSTRACT | FULL TEXT  

Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation
Weiler et al.
Proc. Natl. Acad. Sci. USA 1997;94:5395-5400.
ABSTRACT | FULL TEXT  

Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery et al.
Proc. Natl. Acad. Sci. USA 1997;94:5401-5404.
ABSTRACT | FULL TEXT  

The Molecular Basis of Fragile X Syndrome
Eberhart and Warren
Cold Spring Harb Symp Quant Biol 1996;61:679-687.
ABSTRACT  

Unstable Triplet Repeat Diseases
Monckton and Caskey
Circulation 1995;91:513-520.
ABSTRACT | FULL TEXT  

Fragile X Syndrome: Improving Understanding and Diagnosis
Caskey
JAMA 1994;271:552-553.
ABSTRACT